Trupanion (NASDAQ:TRUP) Downgraded by Zacks Investment Research to “Sell”

Zacks Investment Research cut shares of Trupanion (NASDAQ:TRUP) from a hold rating to a sell rating in a research note issued to investors on Saturday, Zacks.com reports.

According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “

Several other brokerages have also commented on TRUP. Stifel Nicolaus upped their price target on Trupanion from $33.00 to $43.00 and gave the company a hold rating in a research note on Thursday. Northland Securities started coverage on Trupanion in a research note on Thursday, June 25th. They issued a buy rating and a $42.00 price target on the stock. Royal Bank of Canada reaffirmed a buy rating and issued a $40.00 price target on shares of Trupanion in a research note on Monday, June 15th. Lake Street Capital reaffirmed a buy rating and issued a $50.00 price target on shares of Trupanion in a research note on Friday, May 1st. Finally, BidaskClub raised Trupanion from a buy rating to a strong-buy rating in a research note on Thursday, June 18th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. Trupanion currently has a consensus rating of Buy and a consensus target price of $40.25.

NASDAQ:TRUP traded up $0.13 during trading hours on Friday, hitting $50.57. The company had a trading volume of 338,890 shares, compared to its average volume of 302,514. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.22. The company has a 50-day moving average of $44.23 and a 200 day moving average of $33.90. The company has a market cap of $1.78 billion, a P/E ratio of -1,011.40 and a beta of 1.56. Trupanion has a 1 year low of $20.84 and a 1 year high of $53.57.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Thursday, April 30th. The financial services provider reported ($0.03) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.04) by $0.01. Trupanion had a negative return on equity of 1.23% and a negative net margin of 0.40%. The company had revenue of $111.30 million during the quarter, compared to analysts’ expectations of $110.10 million. During the same period in the prior year, the business earned ($0.04) EPS. The firm’s quarterly revenue was up 28.0% on a year-over-year basis. On average, analysts forecast that Trupanion will post -0.04 earnings per share for the current year.

In other Trupanion news, CEO Darryl Rawlings sold 4,000 shares of the stock in a transaction that occurred on Thursday, July 23rd. The stock was sold at an average price of $50.91, for a total transaction of $203,640.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Tricia Plouf sold 17,000 shares of the stock in a transaction that occurred on Thursday, July 16th. The stock was sold at an average price of $48.56, for a total value of $825,520.00. Following the sale, the chief financial officer now directly owns 23,972 shares of the company’s stock, valued at $1,164,080.32. The disclosure for this sale can be found here. Insiders have sold a total of 75,900 shares of company stock worth $3,124,280 in the last 90 days. 13.61% of the stock is currently owned by company insiders.

Institutional investors have recently bought and sold shares of the business. Clarius Group LLC acquired a new stake in shares of Trupanion in the 2nd quarter valued at approximately $205,000. State Street Corp lifted its holdings in shares of Trupanion by 0.7% in the 1st quarter. State Street Corp now owns 577,666 shares of the financial services provider’s stock valued at $15,037,000 after buying an additional 3,792 shares during the period. BNP Paribas Arbitrage SA lifted its holdings in shares of Trupanion by 110.5% in the 1st quarter. BNP Paribas Arbitrage SA now owns 8,923 shares of the financial services provider’s stock valued at $232,000 after buying an additional 4,684 shares during the period. Capital World Investors lifted its holdings in shares of Trupanion by 8.1% in the 1st quarter. Capital World Investors now owns 2,795,507 shares of the financial services provider’s stock valued at $72,767,000 after buying an additional 210,000 shares during the period. Finally, Victory Capital Management Inc. lifted its holdings in shares of Trupanion by 183.1% in the 1st quarter. Victory Capital Management Inc. now owns 48,230 shares of the financial services provider’s stock valued at $1,255,000 after buying an additional 31,192 shares during the period. 92.71% of the stock is owned by institutional investors.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Featured Article: Why are percentage decliners important?

Get a free copy of the Zacks research report on Trupanion (TRUP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.